LULU Lululemon Athletica Inc

Lululemon Athletica designs and retails premium athletic apparel and accessories, anchored by its core yoga and training product lines. Sector: Consumer Discretionary.

Lululemon Athletica Inc (LULU) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

On the question of capital productivity, ROIC is 29.45%, WACC is 9.59%, and the economic spread is 19.86%. On balance, the economic spread is positive and meaningful, suggesting the company are building rather than eroding intrinsic value. Supporting metrics show ROE at 34.58% and ROA at 18.73%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company with credible compounding capacity if current operating execution persists.

From a market pricing perspective, trailing P/E of 11.73, forward P/E of 12.65, PEG of 1.17. With trailing and forward P/E closely aligned, the market appears to be pricing the company on the assumption that earnings remain broadly stable near term. The PEG ratio suggests the market may be underpricing the company's growth trajectory relative to its current multiple. The company carries an aggregate current ratio of 2.26, consistent with adequate near-term liquidity management. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.

The margin stack reads as follows: gross margin sits at 56.60%, operating margin at 19.91%, and free cash flow margin at 8.30%. The gross margin reading points to the company with solid but not outsized pricing power relative to direct costs. The company's operating margins are solid, pointing to overhead management that appears to be a relative strength. FCF margins are in a reasonable range, though there is room for improvement in how efficiently revenues convert to free cash. The profile is not weak, but it is uneven enough that execution and cost control remain central to the forward case.

The forward view combines two signals: the estimated 12-month price change of 15.06%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 0.81% indicating muted but still positive top-line momentum across the company. The forward EPS growth estimate of -7.3% is negative, which complicates the valuation case and suggests current multiples may not be as defensible on a forward basis. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

The overall evidence base is constructive, with more signals pointing up than down and no obvious structural impairment to the forward case.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.